Brief: Stayble Therapeutics Carries Out Directed Issue Of Units
May 5 (Reuters) - Stayble Therapeutics AB STABL.ST: SAID ON FRIDAY CO CARRIES OUT DIRECTED ISSUE OF UNITS TOTALING ABOUT SEK 4.55 MLN SUBSCRIPTION PRICE AT SEK 1.08 PER UNIT, CORRESPONDING TO SEK 0.36 PER SHARE DIRECTED ISSUE OF TOTAL OF 4,212,963 UNITS Source text for Workspace: nWkr2mFdcK Further company coverage: STABL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln